| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | -99.3% |
| R&D Expense | $24.6M | -47.6% |
| SG&A Expense | $32.4M | -12.9% |
| Operating Income | -$55.5M | -144.7% |
| Pre-tax Income | -$54.2M | -143.6% |
| Income Tax | $0 | -100.0% |
| Net Income | -$54.2M | -144.1% |
| EPS (Basic) | -$0.77 | -143.3% |
| EPS (Diluted) | -$0.77 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.9M | -76.1% |
| Current Assets | $131.4M | -31.0% |
| Total Assets | $155.3M | -20.2% |
| Current Liabilities | $7.0M | -52.8% |
| Total Liabilities | $23.0M | +55.4% |
| Stockholders' Equity | $132.3M | -26.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$55.2M | -146.6% |
| Capital Expenditures | $1.2M | +565.4% |
| Investing Cash Flow | -$87.9M | -4725.0% |
| Financing Cash Flow | $181K | -80.0% |
| Free Cash Flow | -$56.5M | -147.7% |
| -143.8% |